Jillian L. Werbeck

1.4k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Jillian L. Werbeck is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jillian L. Werbeck has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jillian L. Werbeck's work include Bone health and treatments (7 papers), Bone Metabolism and Diseases (4 papers) and Cancer Cells and Metastasis (4 papers). Jillian L. Werbeck is often cited by papers focused on Bone health and treatments (7 papers), Bone Metabolism and Diseases (4 papers) and Cancer Cells and Metastasis (4 papers). Jillian L. Werbeck collaborates with scholars based in United States, Italy and Taiwan. Jillian L. Werbeck's co-authors include Thomas J. Rosol, John J. Halliday, Eric C. Holland, Nduka Amankulor, Amanda Katz, Elin Ekström, Jason T. Huse, Alexander Pietras, Kenneth L. Pitter and Chelsea K. Martin and has published in prestigious journals such as Cancer Research, The FASEB Journal and Cell stem cell.

In The Last Decade

Jillian L. Werbeck

17 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth

2014 403 citations Alexander Pietras, Amanda Katz et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jillian L. Werbeck United States	14	534	469	231	192	186	17	1.1k
Marianna B. Ruzinova United States	15	504 0.9×	822 1.8×	286 1.2×	225 1.2×	111 0.6×	36	1.4k
Piotr Jachimczak Germany	13	519 1.0×	697 1.5×	188 0.8×	242 1.3×	114 0.6×	30	1.2k
Sergey Popov United Kingdom	20	316 0.6×	825 1.8×	349 1.5×	177 0.9×	202 1.1×	48	1.5k
Monica Hermanson Sweden	12	307 0.6×	635 1.4×	228 1.0×	183 1.0×	135 0.7×	15	1.2k
Margaret E. Macy United States	19	385 0.7×	521 1.1×	149 0.6×	113 0.6×	256 1.4×	57	1.3k
Mareike Florek United States	18	504 0.9×	560 1.2×	210 0.9×	559 2.9×	87 0.5×	29	1.7k
Richard P. Redvers Australia	16	291 0.5×	441 0.9×	215 0.9×	119 0.6×	183 1.0×	19	1.0k
Christie J. Avraamides United States	6	572 1.1×	782 1.7×	220 1.0×	376 2.0×	95 0.5×	6	1.5k
Amanda Katz United States	10	410 0.8×	689 1.5×	346 1.5×	167 0.9×	125 0.7×	19	1.2k
Evelyn Susanto Australia	7	760 1.4×	623 1.3×	332 1.4×	155 0.8×	108 0.6×	9	1.3k

Countries citing papers authored by Jillian L. Werbeck

Since Specialization

Citations

This map shows the geographic impact of Jillian L. Werbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jillian L. Werbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jillian L. Werbeck more than expected).

Fields of papers citing papers by Jillian L. Werbeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jillian L. Werbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jillian L. Werbeck. The network helps show where Jillian L. Werbeck may publish in the future.

Co-authorship network of co-authors of Jillian L. Werbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Jillian L. Werbeck. A scholar is included among the top collaborators of Jillian L. Werbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jillian L. Werbeck. Jillian L. Werbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lanigan, Lisa G., Blake E. Hildreth, Wessel P. Dirksen, et al.. (2020). In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene. American Journal Of Pathology. 191(2). 335–352. 3 indexed citations

Sasser, Kate, Tineke Casneuf, Amy Axel, et al.. (2016). Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. Breast Cancer Targets and Therapy. 8. 13–13. 20 indexed citations

Pietras, Alexander, Amanda Katz, Elin Ekström, et al.. (2014). Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth. Cell stem cell. 14(3). 357–369. 403 indexed citations breakdown →

Werbeck, Jillian L., Nanda K. Thudi, Chelsea K. Martin, et al.. (2013). Tumor Microenvironment Regulates Metastasis and Metastasis Genes of Mouse MMTV-PymT Mammary Cancer Cells In Vivo. Veterinary Pathology. 51(4). 868–881. 28 indexed citations

Martin, Chelsea K., Wessel P. Dirksen, Lisa G. Lanigan, et al.. (2013). Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone‐invasive oral squamous cell carcinoma. Veterinary and Comparative Oncology. 13(3). 203–217. 15 indexed citations

Martin, Chelsea K., Wessel P. Dirksen, Sherry T. Shu, et al.. (2012). Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. Oral Oncology. 48(6). 491–499. 45 indexed citations

Thudi, Nanda K., Sherry T. Shu, Chelsea K. Martin, et al.. (2011). Development of a brain metastatic canine prostate cancer cell line. The Prostate. 71(12). 1251–1263. 31 indexed citations

Pillai, Smitha P.S., Blake E. Hildreth, Lisa G. Lanigan, et al.. (2011). Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice. Clinical & Experimental Metastasis. 28(4). 377–389. 27 indexed citations

Shu, Sherry T., Wessel P. Dirksen, Lisa G. Lanigan, et al.. (2011). Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formationin vivoand expression of apoptosis regulatory genesin vitro. Leukemia & lymphoma. 53(4). 688–698. 7 indexed citations

10.

Martin, Chelsea K., Jillian L. Werbeck, Nanda K. Thudi, et al.. (2010). Zoledronic Acid Reduces Bone Loss and Tumor Growth in an Orthotopic Xenograft Model of Osteolytic Oral Squamous Cell Carcinoma. Cancer Research. 70(21). 8607–8616. 41 indexed citations

11.

Thudi, Nanda K., Chelsea K. Martin, Sridhar Murahari, et al.. (2010). Dickkopf‐1 (DKK‐1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. The Prostate. 71(6). 615–625. 103 indexed citations

12.

Toribio, Ramiro E., Holly Brown, Chad M. Novince, et al.. (2010). The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice. The FASEB Journal. 24(6). 1947–1957. 51 indexed citations

13.

Hildreth, Blake E., et al.. (2010). PTHrP 1-141 and 1-86 Increase In Vitro Bone Formation. Journal of Surgical Research. 162(2). e9–e17. 14 indexed citations

14.

Studebaker, Adam, Gianluca Storci, Jillian L. Werbeck, et al.. (2008). Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner. Cancer Research. 68(21). 9087–9095. 198 indexed citations

15.

Thudi, Nanda K., Chelsea K. Martin, Murali V.P. Nadella, et al.. (2008). Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. The Prostate. 68(10). 1116–1125. 42 indexed citations

16.

Shu, Sherry T., Murali V.P. Nadella, Wessel P. Dirksen, et al.. (2007). A Novel Bioluminescent Mouse Model and Effective Therapy for Adult T-Cell Leukemia/Lymphoma. Cancer Research. 67(24). 11859–11866. 28 indexed citations

17.

Ramakrishnan, Rathi, Jillian L. Werbeck, Kamal K. Khurana, & Seema A. Khan. (2003). Expression of Interleukin-6 and Tumor Necrosis Factor alpha and Histopathologic Findings in Painful and Nonpainful Breast Tissue. The Breast Journal. 9(2). 91–97. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact